Larimar Therapeutics has filed a notice of a Private Investment in Public Equity (PIPE) offering of securities to raise $172,500,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Larimar Therapeutics is raising $172,500,000.00 in new funding. About Larimar Therapeutics: Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases…